About
Pacira Pharmaceuticals develops and commercializes non-opioid, long-acting local analgesic products for acute postoperative pain management, including its main product Exparel, and is advancing a gene therapy candidate for knee osteoarthritis.
Explore Pacira Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.